| Mr Gregory Lind Taylor Ii, MD | |
|
1520 San Pablo St, Suite 1000, Los Angeles, CA 90033-5310 | |
| (323) 442-5100 | |
| Not Available |
| Full Name | Mr Gregory Lind Taylor Ii |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 1520 San Pablo St, Los Angeles, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972706281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | A98429 (California) | Secondary |
| 207R00000X | Internal Medicine | A98429 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Keck Hospital Of Usc | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usc Care Medical Group Inc | 0446157747 | 1128 |
News Archive
A third of the world's human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of Copenhagen demonstrates that the risk of tuberculosis breaking out is four times as likely if a person also suffers from diabetes. Meanwhile, as a diabetic, a person is five times as likely to die during tuberculosis treatment.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
Pfizer Inc today announced that China's Ministry of Commerce has approved the company's pending acquisition of Wyeth. The Ministry's decision includes Pfizer's commitment to divest certain animal health assets in China.
The Associated Press examines international aid and advocacy groups' reaction to the new U.S. Global Development Policy President Barack Obama unveiled Wednesday at the U.N. Summit on the Millennium Development Goals (MDGs).
› Verified 3 days ago
| Entity Name | Usc Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902846306 PECOS PAC ID: 0446157747 Enrollment ID: O20050512000412 |
News Archive
A third of the world's human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of Copenhagen demonstrates that the risk of tuberculosis breaking out is four times as likely if a person also suffers from diabetes. Meanwhile, as a diabetic, a person is five times as likely to die during tuberculosis treatment.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
Pfizer Inc today announced that China's Ministry of Commerce has approved the company's pending acquisition of Wyeth. The Ministry's decision includes Pfizer's commitment to divest certain animal health assets in China.
The Associated Press examines international aid and advocacy groups' reaction to the new U.S. Global Development Policy President Barack Obama unveiled Wednesday at the U.N. Summit on the Millennium Development Goals (MDGs).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gregory Lind Taylor Ii, MD Po Box 31309, Los Angeles, CA 90031-0309 Ph: (323) 442-5100 | Mr Gregory Lind Taylor Ii, MD 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033-5310 Ph: (323) 442-5100 |
News Archive
A third of the world's human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of Copenhagen demonstrates that the risk of tuberculosis breaking out is four times as likely if a person also suffers from diabetes. Meanwhile, as a diabetic, a person is five times as likely to die during tuberculosis treatment.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
Pfizer Inc today announced that China's Ministry of Commerce has approved the company's pending acquisition of Wyeth. The Ministry's decision includes Pfizer's commitment to divest certain animal health assets in China.
The Associated Press examines international aid and advocacy groups' reaction to the new U.S. Global Development Policy President Barack Obama unveiled Wednesday at the U.N. Summit on the Millennium Development Goals (MDGs).
› Verified 3 days ago
Dr. Linda Fong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-3290 | |
Dr. Robert Peter Gale, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049 Phone: 310-442-9010 | |
Dr. Tarek Alasil, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045 Phone: 310-673-2020 Fax: 310-469-5290 | |
David Michael Tellalian, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048 Phone: 310-358-2300 Fax: 310-358-2308 | |
Dr. Jan B King, M.D., M.P.H. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059 Phone: 323-568-8701 | |
Dr. Caroline Hwang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033 Phone: 323-442-5100 | |
Dr. Jennifer A Fulcher, M.D., PH.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095 Phone: 310-825-7225 |